Trial Profile
Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Vicagrel (Primary) ; Clopidogrel
- Indications Thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Jiangsu Vcare Pharmatech
- 08 Apr 2020 Results assessing the impacts of CYP2C19 polymorphisms on pharmacokinetics and pharmacodynamics of vicagrel in healthy Chinese subjects published in the British Journal of Clinical Pharmacology
- 18 Sep 2019 Status changed from recruiting to completed.
- 06 May 2019 Status changed to recruiting.